Bloomberg Businessweek cover image

Trump Aims to Seal Iran Deal, Says Truce Extension Unlikely

Bloomberg Businessweek

00:00

Compass Pathways' Progress on Psilocybin

Kabir Nath outlines COMP360 trials, efficacy results, and timeline toward potential FDA submission.

Play episode from 32:47
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app